Class II
Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12.
CGMP Deviations
- Recall number
- D-0811-2026
- Report date
- September 9, 2026
- Classification
- Class II
- Status in dataset
- Ongoing
- Recalling firm
- Baxter Healthcare Corporation
- Generic names
- VASOPRESSIN IN 0.9% SODIUM CHLORIDE
- Brand names
- VASOPRESSIN IN 0.9% SODIUM CHLORIDE
- Product NDCs
- 0338-9640, 0338-9647
Code and lot information
Lot # NC193672, NC193795, Exp Date: 04/30/2028; Lot # NC194198, Exp Date: 05/31/2028.
Distribution
US Nationwide; Puerto Rico; and Chile.
Do not stop or change a prescribed medication based only on this page.Contact your pharmacist or prescriber and compare the exact product, manufacturer, NDC, and lot information.
Source and limitations
This page reflects a public openFDA Drug Enforcement record. The dataset was last checked on September 23, 2026. openFDA states that enforcement data should not be used alone to issue public alerts or track the full lifecycle of a recall.
Review the official FDA Drug Recalls page and the underlying openFDA query.